Retraction to keratin 17 is an imaging biomarker in lung cancers
Retraction to: J Thorac Dis 2020;12:5062-6
In the article “Keratin 17 is an imaging biomarker in lung cancers”, J Thorac Dis 2020;12:5062-5066 (1), three authors who made significant contributions to this article were inadvertently not included in the author byline. Drs. Kenneth R. Shroyer, Luisa F. Escobar-Hoyos, and Lucia Roa-Peña should have been listed as authors and the sequence of authors should have been agreed to by all authors prior to publication. A research compliance committee at Stony Brook University has determined that this article unintentionally used the results of the above without appropriate credit to these authors. Furthermore, the committee determined that the IRB approved protocol for this study was not appropriate and thus there was no IRB approval for this paper.
All authors agree with the retraction of the article.
Footnote
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-2023-18/coif). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Bhattacharji P, Moore W, Yaddanapudi K. Keratin 17 is an imaging biomarker in lung cancers. J Thorac Dis 2020;12:5062-6. [Crossref] [PubMed]
